V
Vista Pharmaceuticals
VISTAPH Share Price
Healthcare6.90
as on 27 Feb 2026 at 15:41
BSE
Market Cap
₹43 Cr
PE Ratio
-5.50
ROCE
-9.03%
VISTAPH Fundamentals
Company Valuation
Market Cap (₹ Cr.)
43
PE Ratio
-5.50
PB Ratio
0.95
Dividend Yield
-
ROE
-10.23%
ROCE
-9.03%
Book Value (₹)
7.25
Face Value (₹)
2.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 21.19% | 21.19% | 21.19% | 21.19% | 21.19% |
| Domestic Institutional Investors (DII) | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 34.00% | 33.62% | 33.62% | 33.64% | 33.63% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
VISTAPH Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
524711
NSE Scrip Name
VISTAPH
ISIN
INE427C01021



